XML 62 R51.htm IDEA: XBRL DOCUMENT v3.25.1
Stockholders’ Equity (Details)
3 Months Ended 6 Months Ended
Apr. 03, 2025
USD ($)
Aug. 16, 2024
USD ($)
Aug. 01, 2024
USD ($)
$ / shares
shares
Dec. 21, 2022
USD ($)
Mar. 31, 2025
USD ($)
$ / shares
shares
Mar. 31, 2024
USD ($)
shares
Dec. 31, 2023
USD ($)
shares
Mar. 31, 2025
USD ($)
$ / shares
shares
Mar. 31, 2024
USD ($)
shares
Feb. 28, 2025
$ / shares
Sep. 30, 2024
shares
Jan. 05, 2024
USD ($)
Dec. 01, 2023
USD ($)
Jul. 24, 2023
USD ($)
Stockholders’ Equity [Line Items]                            
Common stock issued (in Shares) | shares         31,385,526     31,385,526     30,816,499      
Fair value change in warrant liability         $ (390,351)   $ (779,796)          
Maximum aggregate common stock offering price       $ 14,500,000               $ 9,300,000 $ 4,800,000 $ 2,600,000
Percentage of gross proceeds       3.00%                    
Amount of common stock of sales agreement $ 0 $ 3,000,000                        
Aggregate offering price         414,037 2,094,196 $ 1,256,271              
Issuance costs incurred         95,929 $ 148,382   95,929 $ 186,080          
At The Market Offering [Member]                            
Stockholders’ Equity [Line Items]                            
Maximum aggregate common stock offering price         $ 8,000,600     $ 8,000,600            
Maximum [Member]                            
Stockholders’ Equity [Line Items]                            
Exercise price per share (in Dollars per share) | $ / shares                   $ 1.19        
Minimum [Member]                            
Stockholders’ Equity [Line Items]                            
Exercise price per share (in Dollars per share) | $ / shares                   $ 1.08        
August 2024 Private Placement [Member]                            
Stockholders’ Equity [Line Items]                            
Common stock issued (in Shares) | shares     2,944,446                      
Warrants issued (in Shares) | shares     2,208,333                      
Purchase price, per unit (in Dollars per share) | $ / shares     $ 0.9                      
Exercise price per share (in Dollars per share) | $ / shares     $ 0.75   $ 1.19     $ 1.19            
Gross proceeds     $ 2,650,000                      
Issuance costs in connection with at-the-market offering program     $ 200,000                      
August 2024 Private Placement [Member] | Risk-Free Interest Rate [Member]                            
Stockholders’ Equity [Line Items]                            
Warrants and rights outstanding, measurement input         3.82     3.82     3.53      
August 2024 Private Placement [Member] | Expected Volatility [Member]                            
Stockholders’ Equity [Line Items]                            
Warrants and rights outstanding, measurement input         99.3     99.3     115.7      
August 2024 Private Placement [Member] | Expected Life [Member]                            
Stockholders’ Equity [Line Items]                            
Warrants and rights outstanding, measurement input         2.34     2.34     2.84      
August 2024 Private Placement [Member] | Expected Dividend Yield [Member]                            
Stockholders’ Equity [Line Items]                            
Warrants and rights outstanding, measurement input         0     0     0      
Common Stock [Member]                            
Stockholders’ Equity [Line Items]                            
Share issued (in Shares) | shares         355,899 1,461,353 868,243              
Aggregate offering price         $ 356 $ 1,461 $ 868              
Common Stock [Member] | At The Market Offering [Member]                            
Stockholders’ Equity [Line Items]                            
Common stock issued (in Shares) | shares         5,544,489     5,544,489            
Share issued (in Shares) | shares         355,899 1,461,353   355,899 2,329,596          
Aggregate offering price         $ 414,037 $ 2,094,196   $ 414,037 $ 3,350,467